DiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic Patients Highlights -- Successfully...
MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 9, 2014) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company announced today it...
MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 3, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE...
MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 23, 2013) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE...
DiaMedica Inc. Announces Results of Annual General and Special Meeting MINNEAPOLIS, MINNESOTA--(Marketwired - Dec 20, 2013) - DiaMedica Inc...
MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 20, 2013) - DiaMedica Inc. (TSX VENTURE:DMA), a biotechnology company focused on diabetes, is pleased...
MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 16, 2013) - /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE...
DiaMedica Inc. Announces Public Offering MINNEAPOLIS, MINNESOTA--(Marketwired - Dec 4, 2013) - DiaMedica Inc. (TSX-VENTURE:DMA), announced...
MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 4, 2013) - DiaMedica Inc. (TSX VENTURE:DMA), announced today that it has filed a preliminary short...
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 20, 2013) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company, has been invited...
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 11, 2013) - DiaMedica Inc. (TSX VENTURE:DMA), announces that the Board of Directors has granted...
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 30, 2013) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company is pleased to...
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 30, 2013) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company announced...
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 30, 2013) - Granite Creek Gold Ltd. (the "Company") (TSX VENTURE:GCX) is pleased to announce that...
MINNEAPOLIS, MINNESOTA--(Marketwired - Aug. 20, 2013) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company, today announced...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.